Tendons, ligaments, fascia, and muscle — the soft tissue system is the architecture that keeps your body moving, protected, and pain-free. When it breaks down, the consequences ripple across your entire kinetic chain.
Soft tissue injuries are the most undertreated category in musculoskeletal medicine. Standard care offers rest, NSAIDs, and physical therapy — all of which manage the symptom while the underlying structural damage persists. Regenerative soft tissue injections target the damaged tissue directly, delivering the biological tools needed to rebuild it.
• Achilles tendinopathy — chronic and insertional
• Patellar tendonitis (jumper’s knee)
• Rotator cuff tendinopathy and partial tears
• Bicipital tendonitis
• Hamstring and quadriceps tendinopathy
• Gluteal tendinopathy (greater trochanteric pain syndrome)
• Ankle ligament sprains — acute and chronic instability
• Knee ligament laxity (MCL, LCL, posterior capsule)
• Sacroiliac joint ligament dysfunction
• Plantar fasciitis — fascial and ligamentous component
• Chronic muscle tears and incomplete healing
• Myofascial trigger points driving referred pain patterns
• Scar tissue and post-surgical adhesions
• IT band syndrome and lateral hip pain
Chait selects from the following based on your tissue pathology, severity, and root cause assessment:
Most practitioners inject and discharge. Chait injects within a structural correction framework.
Using the CNRT® methodology, he identifies the compensation patterns and kinetic chain dysfunctions that are overloading the target tissue. The injection repairs the damage. The CNRT® correction removes the mechanical cause of that damage. Without both, the tissue will simply re-injure under the same load pattern that broke it the first time.
This is why Chait’s soft tissue outcomes are durable — not temporary.
Soft tissue healing is a biological process that takes time. Regenerative injections accelerate and optimize that process — they do not bypass it. Most patients experience:
• 48–72 hours of increased soreness at the injection site — normal inflammatory response
• Initial symptom improvement within 2–4 weeks
• Continued tissue remodeling and strength restoration over 3–6 months
• Durable results that reflect structural repair, not temporary symptom suppression
Regenerative soft tissue injections are not FDA-approved as treatments for all conditions listed. PRP is FDA-cleared as a procedure. Prolotherapy, MSC therapy, and exosome therapy are considered emerging or investigational in some applications. This content is for educational purposes only. Evan Chait is a licensed Physical Therapist and Acupuncturist, not a medical doctor (MD). Always consult a qualified healthcare professional before pursuing any injection-based treatment.
